Plain-English translation of NCT06422078 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a real-world study of benralizumab, a biologic medication already prescribed to you by your doctor for severe eosinophilic asthma. Researchers want to understand how well this medication works and how it affects your daily life when you use it in your normal routine—not in a controlled study setting. They'll track your asthma control, quality of life, and the medications you're taking over about one year.
Severe eosinophilic asthma can be hard to control even with strong medications. While this treatment has been tested in clinical trials, doctors want to know how well it actually works for patients in everyday life, and whether patients need fewer other asthma medications once they start taking it.
You likely qualify if…
You likely don't qualify if…
You will continue taking benralizumab as your doctor has prescribed—this study doesn't change your treatment. Every 4 weeks, you'll answer brief questionnaires about how well your asthma is controlled and how it affects your quality of life. Throughout the study, you'll record your weekly asthma medication use in a diary (on paper or electronically). The study lasts about 52 weeks (one year), and you'll have routine follow-up visits with your doctor as you normally would.
AI-generated summary from trial data · Sep 16, 2026 · Not medical advice
Germany